Locations:
SearchAdvertisement
Three Cleveland Clinic cardiologists size up the ACC/AHA recommendations
‘A gateway to...a new range of therapies for atherosclerosis’
Beyond the headlines on CANTOS, REVEAL, COMPASS
Celecoxib has least impact, followed by naproxen and ibuprofen
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Dr. Steven Nissen shares his take
GLAGOV results boost hopes for coming outcome trials
Dr. Steven Nissen shares why these studies matter
A veteran academic research organization finds its mission more critical than ever
Trial stopped early after evacetrapib fails to budge event rate
Not all coronary calcium is the same, analysis shows
Advertisement
Advertisement